Novavax Q4 EPS $(2.28) Misses $(0.92) Estimate, Sales $357.40M Miss $383.14M Estimate
Novavax (NASDAQ: NVAX) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate of $(0.92) by 147.83 percent. This is a 79.61 percent increase over losses of $(11.18) per share from the same period last year.